Clinical Results and Weight Loss Data Retatrutide has produced some of the most impressive weight loss data seen to date: 11.5% to 16.8% weight loss in type 2 diabetes trials Up to 24% weight loss in obesity studies at 48 weeks Average loss of over 36 pounds in 40 weeks at higher doses In certain populations, including individuals with obesity and joint issues, weight loss exceeded 70 pounds over the course of a year
There are other supplements which can support metabolic health by improving mitochondrial function the right combination depends on each patients specific presentation and priorities
Though squalane is often called an oil, its technically not one
You may not be a candidate if you: Have a personal or family history of medullary thyroid carcinoma (MTC) Have Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Are currently pregnant or breastfeeding Have a known allergy to GLP-1 ingredients Are experiencing severe gastrointestinal issues such as gastroparesis Are under 18 years old Before starting treatment, your provider at Genesis Lifestyle Medicine will review your full medical history to determine whether GLP-1 therapy is safe for you
The data were expressed as Mean SEM (standard error of the mean)
Given the elevated risk of cardiovascular morbidity and mortality in individuals with mood disorders, including bipolar disorder, the cardiovascular benefits associated with GLP-1 agonists could offer another valuable protective mechanism, enhancing the overall health and well-being of patients